STABLE PHARMACEUTICAL COMPOSITION COMPRISING CARBETOCIN AND SUITABLE FOR VAGINAL ADMINISTRATION, AND PREPARATION METHOD THEREFOR

A pharmaceutical composition comprising carbetocin, comprising (percent by weight): 0.5%-7% of carbetocin, 1%-10% of a water-soluble matrix material, 0.5%-5% of an amino acid anionic surfactant, 0.1%-5% of a humectant, and the balance of water. The amino acid anionic surfactant in the pharmaceutical...

Full description

Saved in:
Bibliographic Details
Main Authors LIN, Hao Wen, TAO, An Jin, LING, Ru Guang, YUAN, Jian Cheng, ZHENG, Chun Lian
Format Patent
LanguageChinese
English
French
Published 28.06.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A pharmaceutical composition comprising carbetocin, comprising (percent by weight): 0.5%-7% of carbetocin, 1%-10% of a water-soluble matrix material, 0.5%-5% of an amino acid anionic surfactant, 0.1%-5% of a humectant, and the balance of water. The amino acid anionic surfactant in the pharmaceutical composition can effectively eliminate the clinical difference caused by the individual difference, can effectively and stably stimulate uterine contraction, and can maintain the stability of a drug. L'invention concerne une composition pharmaceutique comprenant de la carbétocine, comprenant (pour cent en poids) : 0,5 % à 7 % de carbétocine, 1 % à 10 % d'un matériau de matrice soluble dans l'eau, 0,5 % à 5 % d'un tensioactif anionique d'acide aminé, 0,1 % à 5 % d'un humectant, et le reste d'eau. Le tensioactif anionique d'acide aminé dans la composition pharmaceutique peut éliminer efficacement la différence clinique provoquée par la différence individuelle, peut stimuler efficacement et de manière stable la contra
AbstractList A pharmaceutical composition comprising carbetocin, comprising (percent by weight): 0.5%-7% of carbetocin, 1%-10% of a water-soluble matrix material, 0.5%-5% of an amino acid anionic surfactant, 0.1%-5% of a humectant, and the balance of water. The amino acid anionic surfactant in the pharmaceutical composition can effectively eliminate the clinical difference caused by the individual difference, can effectively and stably stimulate uterine contraction, and can maintain the stability of a drug. L'invention concerne une composition pharmaceutique comprenant de la carbétocine, comprenant (pour cent en poids) : 0,5 % à 7 % de carbétocine, 1 % à 10 % d'un matériau de matrice soluble dans l'eau, 0,5 % à 5 % d'un tensioactif anionique d'acide aminé, 0,1 % à 5 % d'un humectant, et le reste d'eau. Le tensioactif anionique d'acide aminé dans la composition pharmaceutique peut éliminer efficacement la différence clinique provoquée par la différence individuelle, peut stimuler efficacement et de manière stable la contra
Author TAO, An Jin
LIN, Hao Wen
YUAN, Jian Cheng
ZHENG, Chun Lian
LING, Ru Guang
Author_xml – fullname: LIN, Hao Wen
– fullname: TAO, An Jin
– fullname: LING, Ru Guang
– fullname: YUAN, Jian Cheng
– fullname: ZHENG, Chun Lian
BookMark eNqNy00OgjAUBOAudOHfHZq41cTCQrePUuhLoG3aoktCTF0ZIMEDeHQRPICrmUzmW5NF27VhRd7OQ1IIaiTYErioPHIoKNel0Q49ajV1iw5VTjnYRHjNUVFQKXUVzjrTll4hRzVSSEtU6LyFrz5MR2OFgXmgpfBSp9RLYcXotmT5aJ5D2P1yQ_aZ8FweQ9_VYeibe2jDq77p6MQujMXROQYW__f6ACqHPzM
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate COMPOSITION PHARMACEUTIQUE STABLE COMPRENANT DE LA CARBÉTOCINE ET APPROPRIÉE POUR UNE ADMINISTRATION VAGINALE, ET SON PROCÉDÉ DE PRÉPARATION
一种稳定的含卡贝缩宫素的阴道给药的药用组合物及其制备方法
ExternalDocumentID WO2018113273A1
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2018113273A13
IEDL.DBID EVB
IngestDate Fri Jul 19 16:00:22 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2018113273A13
Notes Application Number: WO2017CN92718
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180628&DB=EPODOC&CC=WO&NR=2018113273A1
ParticipantIDs epo_espacenet_WO2018113273A1
PublicationCentury 2000
PublicationDate 20180628
PublicationDateYYYYMMDD 2018-06-28
PublicationDate_xml – month: 06
  year: 2018
  text: 20180628
  day: 28
PublicationDecade 2010
PublicationYear 2018
RelatedCompanies HYBIO PHARMACEUTICAL CO., LTD
RelatedCompanies_xml – name: HYBIO PHARMACEUTICAL CO., LTD
Score 3.2718074
Snippet A pharmaceutical composition comprising carbetocin, comprising (percent by weight): 0.5%-7% of carbetocin, 1%-10% of a water-soluble matrix material, 0.5%-5%...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title STABLE PHARMACEUTICAL COMPOSITION COMPRISING CARBETOCIN AND SUITABLE FOR VAGINAL ADMINISTRATION, AND PREPARATION METHOD THEREFOR
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180628&DB=EPODOC&locale=&CC=WO&NR=2018113273A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA9jivqmU_FjSkDpk8V9dFv7MCRNszViP2i7ubfRdB0Ksg1XEXzyT_eSberT3i4fF7iEy-WX5O4Qup0Isyms1NTBNme6IcxUT7NGS7dqrUlD5lwVQkX79NvuwHgctUYl9LbxhVFxQj9VcETQqAz0vVD79eLvEstRfyuX9-IVquYPvaTraGt0XDelS6Dm2F0WBk5ANUoBt2l-pNpkUvVOkwBW2oGDdEfqAxva0i9l8d-o9A7RbgjjzYojVPp6qaB9usm9VkF73vrJG8i19i2P0XecEPuJ4dAlkUcoGyQymAGmgRcGMZd3TYqOeMz9PqYkslkSUO5j4js4HvAVN8A-PCR97gMrcTzuc5k3WXLfqY6wJiFZVWCPJW7g4MRlEQO-E3TTYwl1dRBl_Dtz4-fgv9zNU1SezWf5GcJTQDmNdmbmqWEZqZVZmUhrRt3McyPLpjXrHFW3jXSxvfkSHcii_FHVMKuoXLx_5Fdguwtxrab8BzNNk6Q
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEG-IGvFNUeMHahPNnlyEMWB7IKbrCquyj4yCvJF1jGhigMiMiU_-6bYFlCfemrveJW1zvf7a3h0Ad2Nu1bidWLrwzalucivRk9So63alPjZkzVXOVbbPoOH1zadhfVgA7-tYGJUn9EslRxQWlQp7z9V-Pf-_xHLV38rFA38TpNljm7VcbYWOq5YMCdRcp0Wi0A2xhrHAbVoQK54sqt6sIYGVdsUhuyntgQwcGZcy33Qq7UOwFwl90_wIFL5fS6CI17XXSmDfXz15i-bK-hbH4KfHkNMlMPJQ7CNM-kwmM4A49KOwR-Vdk2rHtEeDDsQodggLMQ0gClzY69OltIB9cIA6NBCiyPVpQGXdZCl9rzqKNYnQkgB9wrzQhcwjMRFyJ-C2TRj2dDGU0d_MjV7CzXHXTsHOdDbNzgCcCJRjNFIrS0zbTOzUTnlSMatWlplpOqnY56C8TdPFdvYNKHrM7466NHi-BAeSJX9XGVYZ7OQfn9mV8OM5v1bT_wtNe5aX
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=STABLE+PHARMACEUTICAL+COMPOSITION+COMPRISING+CARBETOCIN+AND+SUITABLE+FOR+VAGINAL+ADMINISTRATION%2C+AND+PREPARATION+METHOD+THEREFOR&rft.inventor=LIN%2C+Hao+Wen&rft.inventor=TAO%2C+An+Jin&rft.inventor=LING%2C+Ru+Guang&rft.inventor=YUAN%2C+Jian+Cheng&rft.inventor=ZHENG%2C+Chun+Lian&rft.date=2018-06-28&rft.externalDBID=A1&rft.externalDocID=WO2018113273A1